vs
盖茨工业（GTES）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是盖茨工业的1.7倍（$1.4B vs $856.2M），瑞思迈净利率更高（27.6% vs 6.0%，领先21.6%），瑞思迈同比增速更快（11.0% vs 3.2%），瑞思迈自由现金流更多（$311.2M vs $251.0M），过去两年瑞思迈的营收复合增速更高（9.0% vs -0.4%）
盖茨工业总部位于美国科罗拉多州丹佛市，是动力传动带及流体动力产品的专业制造商，产品广泛应用于各类工业和汽车领域。公司员工规模超1.5万人，在美洲、欧洲、亚洲、澳洲及中东均设有销售和生产基地。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
GTES vs RMD — 直观对比
营收规模更大
RMD
是对方的1.7倍
$856.2M
营收增速更快
RMD
高出7.7%
3.2%
净利率更高
RMD
高出21.6%
6.0%
自由现金流更多
RMD
多$60.2M
$251.0M
两年增速更快
RMD
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $856.2M | $1.4B |
| 净利润 | $51.3M | $392.6M |
| 毛利率 | 38.0% | 61.8% |
| 营业利润率 | 12.8% | 34.6% |
| 净利率 | 6.0% | 27.6% |
| 营收同比 | 3.2% | 11.0% |
| 净利润同比 | 40.2% | 13.9% |
| 每股收益（稀释后） | $0.19 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTESRMD
| Q4 25 | $856.2M | $1.4B | ||
| Q3 25 | $855.7M | $1.3B | ||
| Q2 25 | $883.7M | $1.3B | ||
| Q1 25 | $847.6M | $1.3B | ||
| Q4 24 | $829.4M | $1.3B | ||
| Q3 24 | $830.7M | $1.2B | ||
| Q2 24 | $885.5M | $1.2B | ||
| Q1 24 | $862.6M | $1.2B |
净利润GTESRMD
| Q4 25 | $51.3M | $392.6M | ||
| Q3 25 | $81.6M | $348.5M | ||
| Q2 25 | $56.5M | $379.7M | ||
| Q1 25 | $62.0M | $365.0M | ||
| Q4 24 | $36.6M | $344.6M | ||
| Q3 24 | $47.6M | $311.4M | ||
| Q2 24 | $70.7M | $292.2M | ||
| Q1 24 | $40.0M | $300.5M |
毛利率GTESRMD
| Q4 25 | 38.0% | 61.8% | ||
| Q3 25 | 39.9% | 61.5% | ||
| Q2 25 | 40.8% | 60.8% | ||
| Q1 25 | 40.7% | 59.3% | ||
| Q4 24 | 40.4% | 58.6% | ||
| Q3 24 | 40.4% | 58.6% | ||
| Q2 24 | 40.4% | 58.5% | ||
| Q1 24 | 38.3% | 57.9% |
营业利润率GTESRMD
| Q4 25 | 12.8% | 34.6% | ||
| Q3 25 | 13.5% | 33.4% | ||
| Q2 25 | 13.1% | 33.7% | ||
| Q1 25 | 14.7% | 33.0% | ||
| Q4 24 | 13.6% | 32.5% | ||
| Q3 24 | 13.6% | 31.6% | ||
| Q2 24 | 15.4% | 31.2% | ||
| Q1 24 | 13.5% | 31.3% |
净利率GTESRMD
| Q4 25 | 6.0% | 27.6% | ||
| Q3 25 | 9.5% | 26.1% | ||
| Q2 25 | 6.4% | 28.2% | ||
| Q1 25 | 7.3% | 28.3% | ||
| Q4 24 | 4.4% | 26.9% | ||
| Q3 24 | 5.7% | 25.4% | ||
| Q2 24 | 8.0% | 23.9% | ||
| Q1 24 | 4.6% | 25.1% |
每股收益（稀释后）GTESRMD
| Q4 25 | $0.19 | $2.68 | ||
| Q3 25 | $0.31 | $2.37 | ||
| Q2 25 | $0.22 | $2.58 | ||
| Q1 25 | $0.24 | $2.48 | ||
| Q4 24 | $0.15 | $2.34 | ||
| Q3 24 | $0.18 | $2.11 | ||
| Q2 24 | $0.26 | $1.97 | ||
| Q1 24 | $0.15 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $812.1M | $1.4B |
| 总债务越低越好 | $2.2B | $403.9M |
| 股东权益账面价值 | $3.3B | $6.3B |
| 总资产 | $7.2B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.67× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资GTESRMD
| Q4 25 | $812.1M | $1.4B | ||
| Q3 25 | $689.4M | $1.4B | ||
| Q2 25 | $719.7M | $1.2B | ||
| Q1 25 | $640.2M | $932.7M | ||
| Q4 24 | $682.0M | $521.9M | ||
| Q3 24 | $574.4M | $426.4M | ||
| Q2 24 | $579.7M | $238.4M | ||
| Q1 24 | $522.2M | $237.9M |
总债务GTESRMD
| Q4 25 | $2.2B | $403.9M | ||
| Q3 25 | $2.2B | $408.7M | ||
| Q2 25 | $2.3B | $658.4M | ||
| Q1 25 | $2.3B | $663.1M | ||
| Q4 24 | $2.4B | $662.9M | ||
| Q3 24 | $2.4B | $667.6M | ||
| Q2 24 | $2.3B | $697.3M | ||
| Q1 24 | $2.3B | $997.0M |
股东权益GTESRMD
| Q4 25 | $3.3B | $6.3B | ||
| Q3 25 | $3.4B | $6.1B | ||
| Q2 25 | $3.3B | $6.0B | ||
| Q1 25 | $3.1B | $5.5B | ||
| Q4 24 | $3.0B | $5.3B | ||
| Q3 24 | $3.1B | $5.2B | ||
| Q2 24 | $3.2B | $4.9B | ||
| Q1 24 | $3.2B | $4.6B |
总资产GTESRMD
| Q4 25 | $7.2B | $8.5B | ||
| Q3 25 | $7.1B | $8.3B | ||
| Q2 25 | $7.2B | $8.2B | ||
| Q1 25 | $6.9B | $7.6B | ||
| Q4 24 | $6.8B | $7.1B | ||
| Q3 24 | $7.1B | $7.2B | ||
| Q2 24 | $7.0B | $6.9B | ||
| Q1 24 | $7.0B | $6.8B |
负债/权益比GTESRMD
| Q4 25 | 0.67× | 0.06× | ||
| Q3 25 | 0.66× | 0.07× | ||
| Q2 25 | 0.72× | 0.11× | ||
| Q1 25 | 0.75× | 0.12× | ||
| Q4 24 | 0.78× | 0.13× | ||
| Q3 24 | 0.76× | 0.13× | ||
| Q2 24 | 0.73× | 0.14× | ||
| Q1 24 | 0.74× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $269.8M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $251.0M | $311.2M |
| 自由现金流率自由现金流/营收 | 29.3% | 21.9% |
| 资本支出强度资本支出/营收 | 2.2% | 2.0% |
| 现金转化率经营现金流/净利润 | 5.26× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $404.9M | $1.8B |
8季度趋势，按日历期对齐
经营现金流GTESRMD
| Q4 25 | $269.8M | $339.7M | ||
| Q3 25 | $98.0M | $457.3M | ||
| Q2 25 | $103.0M | $538.8M | ||
| Q1 25 | $7.3M | $578.7M | ||
| Q4 24 | $190.9M | $308.6M | ||
| Q3 24 | $115.9M | $325.5M | ||
| Q2 24 | $93.8M | $440.1M | ||
| Q1 24 | $-21.0M | $402.0M |
自由现金流GTESRMD
| Q4 25 | $251.0M | $311.2M | ||
| Q3 25 | $80.5M | $414.4M | ||
| Q2 25 | $83.6M | $508.2M | ||
| Q1 25 | $-10.2M | $557.9M | ||
| Q4 24 | $167.6M | $288.0M | ||
| Q3 24 | $94.0M | $307.7M | ||
| Q2 24 | $71.9M | $415.2M | ||
| Q1 24 | $-37.0M | $380.8M |
自由现金流率GTESRMD
| Q4 25 | 29.3% | 21.9% | ||
| Q3 25 | 9.4% | 31.0% | ||
| Q2 25 | 9.5% | 37.7% | ||
| Q1 25 | -1.2% | 43.2% | ||
| Q4 24 | 20.2% | 22.5% | ||
| Q3 24 | 11.3% | 25.1% | ||
| Q2 24 | 8.1% | 33.9% | ||
| Q1 24 | -4.3% | 31.8% |
资本支出强度GTESRMD
| Q4 25 | 2.2% | 2.0% | ||
| Q3 25 | 2.0% | 3.2% | ||
| Q2 25 | 2.2% | 2.3% | ||
| Q1 25 | 2.1% | 1.6% | ||
| Q4 24 | 2.8% | 1.6% | ||
| Q3 24 | 2.6% | 1.5% | ||
| Q2 24 | 2.5% | 2.0% | ||
| Q1 24 | 1.9% | 1.8% |
现金转化率GTESRMD
| Q4 25 | 5.26× | 0.87× | ||
| Q3 25 | 1.20× | 1.31× | ||
| Q2 25 | 1.82× | 1.42× | ||
| Q1 25 | 0.12× | 1.59× | ||
| Q4 24 | 5.22× | 0.90× | ||
| Q3 24 | 2.43× | 1.05× | ||
| Q2 24 | 1.33× | 1.51× | ||
| Q1 24 | -0.53× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTES
| Power Transmission Segment | $536.5M | 63% |
| Fluid Power Segment | $319.7M | 37% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
